denka

Denka Sees Revenue, Profits Drop for Q1 as CR Sales Take Hit From Coronavirus

Denka Co. Ltd. (TYO:4061) has shown a drop to both revenue and profits in its recently posted business results for the April–June quarter of fiscal 2020. The company revealed sales revenue of 76.23 billion yen ($719.68 million) for this first quarter, down by 16.1 percent year-on-year; operating income of 4.4 billion yen, down by 34.8 percent; ordinary income of 5.01...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Pursues Domestic Approval for In Vitro Diagnostic Agent to be Used in COVID-19 Test Kits

Denka Co. Ltd. (TYO:4061) announced on July 20 that it has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), looking here to get domestic regulatory approval for an in vitro diagnostic agent to be used in simple COVID-19 test kits. To help with developing the kit, Denka has pursued collaborative research with the National Institute of Infectious...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Research for Infection Testing Selected for Subsidies Under AMED Project

Denka Co. Ltd. (TYO:4061) announced on June 10 that it has been offered subsidies for an in-house R&D effort focused on infection testing. The company has been working here to develop and test new multiplexed diagnostics technology that targets COVID-19 alongside a range of other infections. The subsidy offer came in on May 28 from the Japan Agency for Medical...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Begins Producing Raw Materials for Avigan as Effort Against Novel Coronavirus

Denka Co. Ltd. (TYO:4061) recently began production of diethyl malonate for use in Avigan, a potential COVID-19 treatment known also by the generic name of favipiravir. This production began on May 16 at the chemical company and chloroprene rubber producer’s Omi Plant in Itoigawa, Niigata Prefecture. Denka sees itself as having a social responsibility to help out with measures against...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka Concludes Technical Agreement With Agilyx for Recycled Styrene Monomer

Denka Co. Ltd. (TYO:4061) has concluded a technology licensing agreement with Agilyx Corp., a global plastic recycling company based in Portland, Oregon, for a chemical recycling project involving used polystyrene from Toyo Styrene Co. Ltd., an equity-method investee of Denka. Denka has begun serious planning for the construction of demonstration equipment at its plant in Ichihara, Chiba Prefecture, that would...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading

Denka to Supply Raw Materials for Potential COVID-19 Treatment Avigan

Denka Co. Ltd. (TYO:4061) recently announced that it has decided to supply diethyl malonate, a raw material for anti-flu drug Avigan, in response to a request from the Japanese government. Also known as favipiravir, Avigan is being touted as a potential treatment for COVID-19 patients. This diethyl malonate production is slated to start in May at Denka’s Omi Plant in...

Please subscribe to read the full story.

[lwa template="modal" register="0"]Subscribe

Continue Reading